Market Insights Consumer OTC Pharmaceuticals

Wound Care - France

France

Revenue in the Wound Care market amounts to €140.80m in 2024. The market is expected to grow annually by 0.38% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975m in 2024).
In relation to total population figures, per person revenues of €2.17 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Wound Care market in France is experiencing steady growth due to several factors. Customers in France prefer advanced wound care products that provide effective and efficient healing solutions.

This preference is driving the demand for innovative wound care products in the market. Additionally, the aging population in France is contributing to the growth of the wound care market as older individuals are more prone to chronic wounds and require specialized care. Customer preferences in the wound care market in France are focused on products that offer faster healing and improved patient comfort.

Advanced wound dressings, such as hydrocolloids and foam dressings, are gaining popularity due to their ability to promote faster healing and provide a moist wound environment. These dressings are also easy to apply and remove, reducing patient discomfort. Furthermore, customers in France are increasingly seeking out wound care products that are cost-effective and provide value for money.

One of the key trends in the wound care market in France is the adoption of digital technologies to enhance wound care management. Digital wound measurement devices and telemedicine platforms are being used to monitor and track the progress of wounds remotely. This trend is driven by the need for efficient wound management, especially in home care settings.

The use of digital technologies allows healthcare professionals to provide timely interventions and reduce the risk of complications. Another trend in the market is the increasing focus on bioactive wound dressings. These dressings contain substances that promote wound healing, such as growth factors and antimicrobial agents.

Bioactive dressings are becoming popular in France as they offer enhanced healing properties and reduce the risk of infection. They are particularly beneficial for chronic wounds that are difficult to heal. Local special circumstances in France, such as the presence of a well-established healthcare system and a high level of healthcare expenditure, contribute to the growth of the wound care market.

The French healthcare system provides universal coverage, ensuring that wound care products are accessible to a wide range of patients. Additionally, the high healthcare expenditure in France allows for investment in advanced wound care technologies and products. Underlying macroeconomic factors, such as the aging population and increasing prevalence of chronic diseases, are driving the growth of the wound care market in France.

The aging population is more susceptible to chronic wounds, such as pressure ulcers and diabetic foot ulcers, which require specialized wound care. The increasing prevalence of chronic diseases, such as diabetes and obesity, also contributes to the demand for wound care products. In conclusion, the wound care market in France is growing steadily due to customer preferences for advanced wound care products, the adoption of digital technologies, and the presence of a well-established healthcare system.

The aging population and increasing prevalence of chronic diseases further contribute to the market growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.